These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20424941)

  • 1. Regression of small resistance artery structural alterations in hypertension by appropriate antihypertensive treatment.
    Agabiti-Rosei E; Rizzoni D
    Curr Hypertens Rep; 2010 Apr; 12(2):80-5. PubMed ID: 20424941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural abnormalities of small resistance arteries in essential hypertension.
    Rizzoni D; Agabiti-Rosei E
    Intern Emerg Med; 2012 Jun; 7(3):205-12. PubMed ID: 21380549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small artery remodeling in diabetes mellitus.
    Rizzoni D; Rosei EA
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):587-92. PubMed ID: 19481431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL; Park JB; Pu Q
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive therapy.
    Schiffrin EL
    Scand Cardiovasc J Suppl; 1998; 47():15-21. PubMed ID: 9540129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.
    Sharifi AM; Li JS; Endemann D; Schiffrin EL
    J Hypertens; 1998 Apr; 16(4):457-66. PubMed ID: 9797191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraclass differences among antihypertensive drugs.
    Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
    Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
    Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
    J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
    Schiffrin EL
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1192-200. PubMed ID: 15607629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
    Dahlöf B
    Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
    Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
    J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
    Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
    Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antihypertensive therapy on hypertensive vascular disease.
    Park JB; Schiffrin EL
    Curr Hypertens Rep; 2000 Jun; 2(3):280-8. PubMed ID: 10981161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical science of calcium channel blocker to inhibit hypertensive vascular injury.
    Takenaka T; Ohno Y; Suzuki H
    Curr Hypertens Rev; 2013 Aug; 9(3):193-201. PubMed ID: 24479753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
    Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
    Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converting enzyme inhibitor-based regimen in hypertensive patients.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Am J Cardiol; 1995 Nov; 76(15):38E-40E. PubMed ID: 7484887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.